97863367 - INDEVR

Information

  • Trademark
  • 97863367
  • Serial Number
    97863367
  • Filing Date
    March 29, 2023
    a year ago
  • Transaction Date
    November 26, 2024
    a month ago
  • Status Date
    June 25, 2024
    6 months ago
  • Published for Opposition Date
    April 30, 2024
    8 months ago
  • Location Date
    June 25, 2024
    6 months ago
  • Status Code
    688
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    STEEL, ALYSSA
  • Attorney Docket Number
    339589
    Attorney Name
    Gary B. Chapman
    Law Office Assigned Location Code
    N60
  • Owners
Mark Drawing Code
3
Mark Identification
INDEVR
Case File Statements
  • DM0000: The mark consists of the stylized wording "inDevR" with the dot over the "i" being stylized with a central solid circle and four open circles arranged around the central solid circle. A line extends from the central solid circle to each of the open circles.
  • GS0091: Kits comprised of laboratory instruments, recorded software, and reagents for quantifying antigen(s), viral protein(s), serum antibodies, nucleic acids, or polypeptides from vaccines, virus samples, and serum samples
  • PM0001: ENDEAVOR
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0011: Assays and reagents for vaccine characterization for research purposes; Assays and reagents for virus characterization for research purposes; serological assays and reagents for research purposes; kits composed of assays and reagents for vaccine characterization and virus characterization, and serological assays and reagents all for research purposes; kits composed of assays and reagents for quantifying antigen(s), viral protein(s), serum antibodies, nucleic acids, or polypeptides from vaccines, virus samples, and serum samples for research purposes
  • GS0421: Testing services for others in the fields of vaccine research and development, and antigen characterization; Testing services for others, namely, testing of samples obtained from vaccine manufacturing processes; development of custom assays for others in the fields of vaccine development, serological testing, nucleic acid detection, immunoactive agent detection; research and development in the fields of vaccine characterization, virus characterization, and serological assays
Case File Event Statements
  • 4/1/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 4/22/2023 - a year ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSM
  • 12/22/2023 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/3/2024 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/3/2024 - a year ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/3/2024 - a year ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/26/2024 - 9 months ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/26/2024 - 9 months ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/21/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/27/2024 - 9 months ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/28/2024 - 9 months ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/10/2024 - 9 months ago
    12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/30/2024 - 8 months ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/30/2024 - 8 months ago
    14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/25/2024 - 6 months ago
    15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 11/25/2024 - a month ago
    16 - SOU TEAS EXTENSION RECEIVED Type: EEXT